These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 34608194)
1. Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections. Heemskerk MT; Korbee CJ; Esselink JJ; Dos Santos CC; van Veen S; Gordijn IF; Vrieling F; Walburg KV; Engele CG; Dijkman K; Wilson L; Verreck FAW; Ottenhoff THM; Haks MC Sci Rep; 2021 Oct; 11(1):19634. PubMed ID: 34608194 [TBL] [Abstract][Full Text] [Related]
2. Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy. Kilinç G; Boland R; Heemskerk MT; Spaink HP; Haks MC; van der Vaart M; Ottenhoff THM; Meijer AH; Saris A Microbiol Spectr; 2024 Aug; 12(8):e0016724. PubMed ID: 38916320 [TBL] [Abstract][Full Text] [Related]
3. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis. Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748 [TBL] [Abstract][Full Text] [Related]
4. Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials. Korbee CJ; Heemskerk MT; Kocev D; van Strijen E; Rabiee O; Franken KLMC; Wilson L; Savage NDL; Džeroski S; Haks MC; Ottenhoff THM Nat Commun; 2018 Jan; 9(1):358. PubMed ID: 29367740 [TBL] [Abstract][Full Text] [Related]
5. Identification of kinase inhibitors as potential host-directed therapies for intracellular bacteria. van den Biggelaar RHGA; Walburg KV; van den Eeden SJF; van Doorn CLR; Meiler E; de Ries AS; Fusco MC; Meijer AH; Ottenhoff THM; Saris A Sci Rep; 2024 Jul; 14(1):17225. PubMed ID: 39060313 [TBL] [Abstract][Full Text] [Related]
7. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages. Lee HJ; Ko HJ; Kim SH; Jung YJ PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638 [TBL] [Abstract][Full Text] [Related]
8. Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy. Liu Y; Wang J; Yang J; Xia J; Yu J; Chen D; Huang Y; Yang F; Ruan Y; Xu JF; Pi J J Nanobiotechnology; 2024 Oct; 22(1):608. PubMed ID: 39379986 [TBL] [Abstract][Full Text] [Related]
11. Autophagy: A new strategy for host-directed therapy of tuberculosis. Paik S; Kim JK; Chung C; Jo EK Virulence; 2019 Dec; 10(1):448-459. PubMed ID: 30322337 [TBL] [Abstract][Full Text] [Related]
12. Berbamine promotes macrophage autophagy to clear Zhang S; Zhou X; Ou M; Fu X; Lin Q; Tao X; Wang Z; Liu A; Li G; Xu Y; Zhang G mBio; 2023 Aug; 14(4):e0027223. PubMed ID: 37382506 [TBL] [Abstract][Full Text] [Related]
13. The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection. Giraud-Gatineau A; Coya JM; Maure A; Biton A; Thomson M; Bernard EM; Marrec J; Gutierrez MG; Larrouy-Maumus G; Brosch R; Gicquel B; Tailleux L Elife; 2020 May; 9():. PubMed ID: 32369020 [TBL] [Abstract][Full Text] [Related]
14. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of Pahari S; Negi S; Aqdas M; Arnett E; Schlesinger LS; Agrewala JN Autophagy; 2020 Jun; 16(6):1021-1043. PubMed ID: 31462144 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis. Vesenbeckh S; Krieger D; Bettermann G; Schönfeld N; Bauer TT; Rüssmann H; Mauch H Tuberculosis (Edinb); 2016 May; 98():27-9. PubMed ID: 27156615 [TBL] [Abstract][Full Text] [Related]
16. Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Improves Host Control of van Doorn CLR; Schouten GK; van Veen S; Walburg KV; Esselink JJ; Heemskerk MT; Vrieling F; Ottenhoff THM Front Immunol; 2021; 12():739938. PubMed ID: 34552598 [TBL] [Abstract][Full Text] [Related]
17. Small Molecule Targeting PPM1A Activates Autophagy for Yu Z; Liang YC; Berton S; Liu L; Zou J; Chen L; Xu Z; Luo C; Sun J; Yang W J Med Chem; 2024 Jul; 67(14):11917-11936. PubMed ID: 38958057 [No Abstract] [Full Text] [Related]
18. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]